It is plausible that reactivation of telomerase, which is usually achieved in cancer through mutations of the TERT promoter that hinder a repressor binding site, may require time for selection of the right mutation; therefore a quicker, although dangerous, mechanism to maintain telomere length and allow cancer growth, is through the engagement of ALT mechanisms. This evidence concerns the gene TERT and cancer.